Anti-VSV-G [M55]
AB03913-23.0
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Overview
- SupplierAbsolute Antibody
- Product NameAnti-VSV-G [M55]
- Delivery Days Customer9
- Antibody SpecificityThis antibody reacts with a defined subsite within the major antigenic site of VSV-G. The exact epitope is not defined.
- Application Supplier NoteThis stable, recombinant single-chain Fv-Ckappa (scFv-Ckappa) antibody fragment was generated by protoplast fusion of J558L myeloma cells with Escherichia coli K803 transformed with an appropriate scFv-Ckappa expression construct. The aptly named M55 scFv-Ckappa expression construct - containing a CDR2 Ser55-to-Arg substitution (T-to-G transition at the third base), found in the VH chain of several hypermutated antibodies (VI22, VI43, and VI53) - was derived from the secondary antibody clone VI24. M55 binds a defined subsite within the major antigenic site of VSV-G. However, the exact binding site in the subunit is not defined. M55 binding to VSV-G was measured using solid-phase ELISA. The VH Ser55-to-Arg substitution in M55, which is not found in its parental clone VI24, increased monovalent binding by about 10-fold compared with M0 (the germline derived scFv-Ckappa). Furthermore, crosslinking with HRP labeled mouse anti-Ckappa antibodies improved M55 binding 10-fold (Kalinke et al., 2000; PMID: 10963674).
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDM55
- HostRabbit
- IsotypeIgG
- Protein IDP0C2X0
- Protein NameGlycoprotein G
- ReactivityVirus
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203